Request Information

To receive further information on GeneNews please fill out the form below and check the appropriate boxes.

	Send me an investor package
	Add me to the GeneNews Email list
	Add me to the GeneNews Mailing list

* indicates a required field

home-side

"Patients in general, want to avoid colonoscopy both because of the procedure itself and the bowel preparation necessary. Two years ago a blood test became available to we physicians in Toronto which greatly facilitates the understanding of the potential for cancer of the colon and the advice we give to our patients when screening for colorectal cancer. ColonSentry is now incorporated into the blood draw associated with an annual physical, when appropriate."

Dr. Ron Porter,
Medical Director, Virtual Wellness Institute, Toronto, Ontario.
v-w-i.com
"I have been offering ColonSentry as colorectal cancer option to my patients for over a year. The test is patient friendly in that it consist of a simple blood test. It provides actionable information on the patient 's current risk for having the disease and helps facilitate decision making regarding next steps . It is also useful for colonoscopy-compliant patients as an interval monitoring solution. "

Dr. F. Klajner MD, PhD, CCFP
Medical Director, Royal Health Care Centre

May 15	GeneNews Reports Q1 2013 Financial Results
Apr 15	GeneNews Announces Annual Shareholder Meeting
Mar 26	GeneNews Reports Q4 and Full Year 2012 Financial Results
Feb 22	GeneNews Extends Term of Certain Warrants